Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives.

We surveyed faculty and residents from seven hospitals affiliated with three academic internal medicine training programs about their perceptions of the informational and service benefits vs the risks of ethical compromise involved in interactions with pharmaceutical sales representatives. Questionnaires were returned by 467 (81%) of 575 physicians surveyed. Residents and faculty generally had somewhat negative attitudes toward the educational and informational value of detailing activities at their institutions but indicated that representatives supported important conferences and speakers. Residents were more likely than faculty to perceive contacts with sales representatives as potentially influencing physician decision making. Sixty-seven percent of faculty and 77% of residents indicated that physicians could be compromised by accepting gifts. More than half of the physicians who suggested that such compromise was possible indicated that acceptance of gifts worth more than +100 from drug companies would be likely to compromise a physician's independence and objectivity. A majority of both faculty and house staff favored eliminating presentations by pharmaceutical representatives at their hospitals. Only 10% thought they had had sufficient training during medical school and residency regarding professional interaction with sales representatives.

[1]  G Eaton,et al.  General practitioners' views of information about drugs. , 1976, The Journal of the Royal College of General Practitioners.

[2]  R. Ferguson Training the resident to meet the detail men. , 1989, JAMA.

[3]  The relationship between physicians and the pharmaceutical industry: a report of the Royal College of Physicians. , 1986, Journal of the Royal College of Physicians of London.

[4]  P. Palmisano,et al.  Teaching drug promotion abuses to health profession students. , 1980, Journal of medical education.

[5]  Getting good value from drug reps , 1983, Drug and therapeutics bulletin.

[6]  D. Worthen Prescribing influences: an overview 1 , 1973 .

[7]  M. Chren,et al.  Doctors, drug companies, and gifts. , 1991, JAMA.

[8]  D. Worthen Prescribing influences: an overview. , 1973, British journal of medical education.

[9]  J. Lexchin Pharmaceutical Promotion in Canada: Convince Them or Confuse Them , 1987, International journal of health services : planning, administration, evaluation.

[10]  R Hartley,et al.  Scientific versus commercial sources of influence on the prescribing behavior of physicians. , 1982, The American journal of medicine.

[11]  Shulkin Dj Cost estimates of diagnostic procedures. , 1988 .

[12]  G Eaton,et al.  Sources of drug information used by general practitioners. , 1976, The Journal of the Royal College of General Practitioners.

[13]  D P Connelly,et al.  Knowledge resource preferences of family physicians. , 1990, The Journal of family practice.

[14]  T. Caplow,et al.  Factors Influencing the Selection of Pharmaceutical Products , 1954 .

[15]  Raymond A. Dombroski,et al.  Book ReviewOxorn-Foote Human Labor and Birth , 1986 .

[16]  A. Shaughnessy Drug promotion in a family medicine training center. , 1988, JAMA.

[17]  S E Goldfinger,et al.  A matter of influence. , 1987, The New England journal of medicine.